Provided By GlobeNewswire
Last update: May 8, 2025
Responds to Recent Public Stockholder Communications
Urges Stockholders to Protect Their Investment by Voting “FOR” the Company’s Highly Qualified Director Nominees
KEROS THERAPEUTICS INC
NASDAQ:KROS (7/28/2025, 8:00:02 PM)
14.51
+0.05 (+0.35%)
Find more stocks in the Stock Screener